TruBridge, Inc. (TBRG)
NASDAQ: TBRG · Real-Time Price · USD
27.52
-0.59 (-2.10%)
Mar 31, 2025, 4:00 PM EDT - Market closed
TruBridge Revenue
In the year 2024, TruBridge had annual revenue of $342.65M with 1.99% growth. TruBridge had revenue of $90.84M in the quarter ending December 31, 2024, with 10.26% growth.
Revenue (ttm)
$342.65M
Revenue Growth
+1.99%
P/S Ratio
1.15
Revenue / Employee
$107,077
Employees
3,200
Market Cap
393.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 342.65M | 6.69M | 1.99% |
| Dec 31, 2023 | 335.96M | 9.31M | 2.85% |
| Dec 31, 2022 | 326.65M | 46.02M | 16.40% |
| Dec 31, 2021 | 280.63M | 16.14M | 6.10% |
| Dec 31, 2020 | 264.49M | -10.15M | -3.69% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
TBRG News
- 17 days ago - TruBridge Announces Participation in the KeyBanc Capital Markets Healthcare Forum - Business Wire
- 20 days ago - TruBridge, Inc. (TBRG) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 21 days ago - TruBridge Announces Fourth Quarter and Full Year 2024 Results and Provides Initial 2025 Outlook - Business Wire
- 4 weeks ago - TruBridge Announces Fourth Quarter and Year-End 2024 Conference Call to Be Held Monday, March 10, 2025 - Business Wire
- 6 weeks ago - TruBridge Selected by Cibolo Health as a Preferred Partner for RCM Technology and Services - Business Wire
- 6 weeks ago - TruBridge Announces Two Directors to Join Its Board as a Part of Cooperation Agreements With Pinetree Capital and Ocho Investments - Business Wire
- 2 months ago - TruBridge Chosen by Lady of the Sea General Hospital as Advanced Technology Partner - Business Wire
- 3 months ago - TruBridge Names Merideth Wilson as Financial Health General Manager - Business Wire